Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Neuromuscular electrical stimulation to improve blood sugar control after spinal cord injury

Official title: Novel Use of Neuromuscular Electrical Stimulation to Improve Glucose Control in Individuals With Spinal Cord Injury

Run by University of Bath · NCT07099911 · Data updated 2026-11-12

This trial will test whether neuromuscular electrical stimulation (NMES) can improve blood sugar control in adults with spinal cord injury compared with a sham condition and with people without injury.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Bath
Academic / other
Locations1 site (Bath, United Kingdom)
StatusRecruiting
StartedAugust 8, 2025
Main results expectedSeptember 1, 2026
Study endsSeptember 1, 2027
Registry record updatedAugust 7, 2025
Trial IDNCT07099911 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (18+) who are >1 year post spinal cord injury (AIS A–C, injury level C5–L2) who can give informed consent, with non-injured adults eligible as control participants.

Probably not a fit

People with diagnosed type 2 diabetes or taking glucose-lowering medications, those who cannot tolerate NMES, pregnant individuals, or those with recent lower-limb fractures or peripheral nerve injury are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with spinal cord injury and non-injured controls will undergo an oral glucose tolerance test with dual stable isotope tracers to measure how an acute bout of NMES changes glucose handling compared with a sham session. The primary comparison is peripheral glucose uptake after a single NMES session versus sham, and between injured and non-injured groups. People with SCI will then be given instructions to use NMES at home for two weeks to assess real-world feasibility. In-depth interviews will be conducted to capture acceptability and identify practical barriers to home use.

Why it matters

Potential benefit: If successful, NMES could offer a non-drug way to improve glucose control and reduce metabolic risk in people with spinal cord injury.

How similar studies have gone: Smaller prior studies have shown NMES can increase peripheral glucose uptake in people with SCI, but using a dual stable isotope tracer OGTT and a two-week home-feasibility component is a relatively novel combination.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

We are asking all individuals who meet our study criteria if they would like to take part. We are looking for both males and females who meet all the criteria on this list for either SCI or non-injured individuals:

Individuals with SCI:

* \>1-year postinjury.
* 18 years of age or above
* American Spinal Cord Injury Impairment Scale A-C.
* Level of Injury, Cervical 5-Lumbar 2.
* Have capacity to provide informed consent.

Non-injured individuals:

• 18 years of age or above

Exclusion Criteria:

* Has been diagnosed with type 2 diabetes, or actively taking a pharmaceutical to address elevated blood glucose.
* Unable to understand explanations and/or provide informed consent.
* If you cannot tolerate the NMES intervention
* Is pregnant or planning to become pregnant during the study duration

SCI only:

* Recently trained with electrical stimulation (\< 6 months)
* Recent history of lower limb fractures
* Peripheral nerve injury to lower extremities
* Unresolved pressure ulcers
* Known lower motor neuron injury.
* If the research team cannot induce visible or palpable contractions of the quadricep muscle with NMES
* If they cannot tolerate the NMES intervention
* Has previously experienced uncontrolled autonomic dysreflexia

Where it's running

  • Department for Health, University of Bath
    Bath, United Kingdom, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.